Santhera Pharmaceuticals Holding AG (OTCMKTS:SPHDF) Sees Significant Increase in Short Interest

Santhera Pharmaceuticals Holding AG (OTCMKTS:SPHDF) saw a significant growth in short interest during the month of February. As of February 28th, there was short interest totalling 3,600 shares, a growth of 300.0% from the February 13th total of 900 shares. Based on an average daily volume of 0 shares, the short-interest ratio is currently ∞ days.

Santhera Pharmaceuticals Price Performance

SPHDF opened at $16.00 on Friday. The company’s 50 day simple moving average is $9.95 and its 200-day simple moving average is $10.73. Santhera Pharmaceuticals has a one year low of $16.00 and a one year high of $16.00.

About Santhera Pharmaceuticals

Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and commercializes medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the European Union and internationally. The company's lead pipeline candidate includes Vamorolone, which is being developed for the treatments of Duchenne muscular dystrophy (DMD).